One counter argument to the pharmaceutical industry conspiracy theory is that it is simply not financially viable for pharmaceutical companies to focus solely on developing cures. While it is true that some diseases can be cured, many others cannot be cured, at least not yet. In these cases, pharmaceutical companies may focus on developing treatments that can help to manage the symptoms of the disease and improve the quality of life for patients. These treatments may not be cures, but they can still be an important part of managing the disease and improving the health of patients.
Furthermore, it is important to consider the financial costs associated with developing new drugs and therapies. The process of developing a new drug or therapy can be costly and time-consuming, with estimates suggesting that it can take up to 10-15 years and billions of dollars to bring a new drug to market. Given these costs, it is not financially feasible for pharmaceutical companies to focus solely on developing cures, especially when the likelihood of success is low. Instead, they must also consider the potential market for the treatment and the potential return on investment.
Finally, it is important to recognize that the development of new drugs and therapies is a complex and uncertain process that is influenced by a variety of factors, including scientific and technical challenges, regulatory hurdles, and market dynamics. While it is certainly the goal of many pharmaceutical companies to find cures for diseases, it is not always possible to do so. It is important to approach the development of new treatments and therapies with a sense of realism and to recognize that progress may be slow and incremental.